BioSpace News Archive

What do you think is how much time is required for vaccine development? In a pandemic, the timeline is less than normal. Want to know why? Read the article and find.

Therapies developed using E3 ligase proteins will get a potent infusion, as AbbVie combines its commercialization expertise with Frontier Medicine’s proprietary chemoproteomics platform to develop potentially efficacious therapies for difficult-to-drug protein targets.

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

RLS-0071 positioned as a novel pharmacological intervention to improve survival and cognitive outcomes for newborns affected by devastating disease

New data highlight role of leukotriene B4 (LTB4) in the pathophysiology of retinal inflammation and degeneration I n the experimental allergic uveitis (EAU) disease model nomacopan reduce d Th17 effector T cell and macrophage activity in addition to known downregulation of neutrophils Long-acting forms of nomacopan were at least as effective in downregulating disease in EAU model as standard of care dexamethasone, which is associated with steroid related side effects

2021 Awards Recognize Top Urologists, Honor Service to Specialty and Society

In support of public health efforts to encourage flu vaccinations and to provide an easy mode of transportation to flu shot locations across Metro-Boston, Blue Cross Blue Shield of Massachusetts (“Blue Cross”) will offer free Bluebikes rides during National Influenza Vaccination Week , December 6-12 . Complimentary trips will be av

Attune Medical, a breakthrough medical device company with a technology platform based on targeted temperature management using the esophageal space, has achieved significant corporate milestones as part of the company’s aggressive growth plan. The company’s ongoing support of clinical research for emerging temperature management applications and the ensoETM has resulted in the first major peer-reviewed clinical public

Scientist.com, the healthcare industry’s leading marketplace for outsourced research, and Discovery Life Sciences™ (Discovery), a global leader in biospecimen solutions, genomic, cell and immunohistochemistry (IHC) services, have partnered to offer researchers online access to Illumina’s TruSight™ Oncology 5